Mycronic (MYCR) Q3 2025 earnings summary

Executive summary

• Q3 order intake surged 67% year-over-year to SEK 2.431 billion, led by Pattern Generators and Global Technologies, with all divisions contributing.

• Net sales declined 4% year-over-year to SEK 1.709 billion, mainly due to lower Pattern Generators sales, though High Volume and Global Technologies grew.

• EBIT dropped to SEK 255 million (margin 15%), down from SEK 547 million and 31% last year, primarily due to product mix in Pattern Generators.

• Order backlog increased to nearly SEK 4.8 billion, reflecting strong future demand.

• Agreement signed to acquire Cowin DST in South Korea, pending regulatory approval.

Financial highlights

• Order intake rose 67% year-over-year to SEK 2.431 billion.

• Net sales rolling 12 months reached SEK 7.976 billion; EBIT margin R12 at 27%.

• Aftermarket revenue R12 at SEK 1.981 billion, representing 25% of net sales.

• Cash and equivalents at SEK 2 billion at quarter-end; net cash position SEK 1.641 billion.

• Book-to-bill ratio in Q3 was 1.4, indicating strong order momentum.

Outlook and guidance

• Full-year and 2025 net sales guidance maintained at SEK 7.5 billion.

• Confident in filling production capacity through 2026, with ongoing efforts to secure orders.

• Electronics and semiconductor markets forecast strong growth in 2025, supporting positive demand outlook.

• No significant macro hesitation among customers, but longer decision cycles have become the norm.